These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33205919)

  • 1. Improved platelet counts during prolonged tranexamic therapy for Quebec platelet disorder implicate the underlying fibrinolytic defect as the cause of lower platelet counts.
    Hayward CPM; Tasneem S; Rivard GE
    Int J Lab Hematol; 2020 Dec; 42(6):e274-e276. PubMed ID: 33205919
    [No Abstract]   [Full Text] [Related]  

  • 2. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment.
    Blavignac J; Bunimov N; Rivard GE; Hayward CP
    Semin Thromb Hemost; 2011 Sep; 37(6):713-20. PubMed ID: 22102275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited disorders of the fibrinolytic pathway.
    Jain S; Acharya SS
    Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis and tranexamic acid: mechanistic principles.
    Draxler DF; Medcalf RL
    ANZ J Surg; 2020 Apr; 90(4):410-411. PubMed ID: 32339417
    [No Abstract]   [Full Text] [Related]  

  • 5. Computational model of tranexamic acid on urokinase mediated fibrinolysis.
    Wu TB; Orfeo T; Moore HB; Sumislawski JJ; Cohen MJ; Petzold LR
    PLoS One; 2020; 15(5):e0233640. PubMed ID: 32453766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid: Beyond antifibrinolysis.
    Prudovsky I; Kacer D; Zucco VV; Palmeri M; Falank C; Kramer R; Carter D; Rappold J
    Transfusion; 2022 Aug; 62 Suppl 1():S301-S312. PubMed ID: 35834488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial.
    Jimenez JJ; Iribarren JL; Lorente L; Rodriguez JM; Hernandez D; Nassar I; Perez R; Brouard M; Milena A; Martinez R; Mora ML
    Crit Care; 2007; 11(6):R117. PubMed ID: 17988379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.
    Santos AT; Kalil RA; Bauemann C; Pereira JB; Nesralla IA
    Braz J Med Biol Res; 2006 Jan; 39(1):63-9. PubMed ID: 16400465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 10. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basis of antifibrinolytic therapy.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():35-40. PubMed ID: 6159375
    [No Abstract]   [Full Text] [Related]  

  • 12. Tranexamic acid use during coronary artery bypass grafting.
    Rubens F; Wells P
    Ann Thorac Surg; 1996 Feb; 61(2):774-5. PubMed ID: 8572821
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of tranexamic acid with aprotinin in pediatric cardiac surgery.
    Chauhan S
    Ann Card Anaesth; 2015; 18(1):27-8. PubMed ID: 25566707
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood coagulation and fibrinolysis in wound healing].
    Sedlarik K
    Z Arztl Fortbild (Jena); 1977 Aug; 71(15):722-5. PubMed ID: 335677
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients.
    Sabovic M; Zupan IP; Salobir B; Zupan I; Cernelc P; Lavre J; Vujkovac B
    Thromb Haemost; 2005 Dec; 94(6):1245-50. PubMed ID: 16411401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
    Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
    Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure.
    Mezzano D; Panes O; Muñoz B; Pais E; Tagle R; González F; Mezzano S; Barriga F; Pereira J
    Thromb Haemost; 1999 Oct; 82(4):1250-4. PubMed ID: 10544908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective observational study of the effect of dual antiplatelet therapy with tranexamic acid treatment on platelet function and bleeding after cardiac surgery.
    Amour J; Garnier M; Szymezak J; Le Manach Y; Helley D; Bertil S; Ouattara A; Riou B; Gaussem P
    Br J Anaesth; 2016 Dec; 117(6):749-757. PubMed ID: 27956673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on tranexamic acid in surgery.
    Balogh ZJ; King KL
    ANZ J Surg; 2020 Apr; 90(4):409. PubMed ID: 32339435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.